(L-R) Prof. Ran Kornowski, Amos Ben Yosef, transplant recipient, and Dr. Schmuel Fuhs
Gene transfer to the heart is no longer a script for science fiction. Prof. Ran Kornowski, Director of the Cardiac Catheterization Institute and Catheterzation Laboratories at Rabin Medical Center, conceived of the idea of gene transplantation seven years ago. After completing preliminary work, he and Dr. Shmuel Fuchs, a senior cardiologist, teamed up with researchers in the USA to develop this innovative technique in collaboration with GenVec and Biosense- Webster, a Johnson & Johnson company. Prof. Kornowski used a novel gene therapy approach to treat Amos Ben Yosef, a 68-year-old man, of the case of angina pectoris because Amos could no longer undergo any other surgical or catheterbased interventions. Two years of trials are now underway with the hope that the newly created blood cells will enhance blood flow to the heart and improve its function.
A distinguished heart surgeon
from Rabin Medical Center
in Israel visited South Florida in
April to discuss with the medical
community new technologies in
minimally invasive heart surgery
using robotics, so that patients
may resume activities within
three days.
Dr. Yael Graif of the Allergy and Immunology Clinic at Israel’s Rabin Medical Center’s Pulmonary Institute recently led a study examining the link between asthma and migraines.
What happens when caffeine and Plavix (a common blood thinning medication used by heart patients) come together?